Info: 60 Veg. Capsules - 500 mg
The principal applications for AHCC (short for: Active Hexose Correlated Compound) approved by Health Canada include use for: immune system support, healthy inflammatory response, and normal cell production and differentiation.
Info: 60 Veg. Capsules - 500 mg
The principal applications for AHCC (short for: Active Hexose Correlated Compound) approved by Health Canada include use for: immune system support, healthy inflammatory response, and normal cell production and differentiation.
Product Notes:
Mushrooms have been used in a number of traditional medicine frameworks for aeons, of course, but they are increasingly gaining traction in Western medicine, as well, as they become the focus of modern research.
AHCC® (Active Hexose Correlated Compound) is a proprietary extract produced from the mycelia (the thread-like 'root' of a mushroom or its spores) of specially-cultivated and hybridized Shiitake mushrooms in Japan, where it is a popular alternative medicine. Its active ingredients include acetylated alpha-glucan, for optimal bioavailability.
Recent research has shown AHCC has the ability to clear high-risk human papillomavirus (HPV) infections.
Ingredients:
Each capsule contains:
AHCC® Proprietary Blend shiitake mycelium extract: 500 mg
Non-medicinal ingredients: Alpha-cyclodextrin, dextrin, microcrystalline cellulose Carnauba wax.
Non-GMO. Gluten Free. Suitable for vegetarians/vegans.
AOR guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, nuts, peanuts, sesame seeds, sulphites, mustard, soy, dairy, eggs, fish, shellfish or any animal byproduct.
Suggested Usage:
Adult Dosage: Take 1 to 2 capsules one to three times daily, preferably without food, or as directed by a qualified health care practitioner.
Warnings:
Do not take if you are pregnant or breastfeeding or if you are allergic to corn. Nausea and diarrhea has been known to occur; in which case, discontinue use.
Health Canada Natural Product Number: 80036494.
Supporting Science:
Smith, Judith A et al. “From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus Infections.” Frontiers in Oncology, 2019.
Smith, Judith A et al. “AHCC® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections.” Frontiers in Oncology, 2022.